MedTrace Logo

Growth of Preterm Infants Fed a Infant Milk Formula Containing High Versus Low Amounts of Beta-palmitate

NCT04541095 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-01-25

No results posted yet for this study

Summary

The aim of this study is to assess weight gain of preterm infants (gestational age lower than 32 weeks) fed infant milk formula with about 60% beta-palmitate (EX\_IMF) vs infant milk formula with similar macronutrient, mineral and fatty acid composition but lower amounts of beta-palmitate (ST\_IMF). Own mother milk (OMM) fed infants will serve as reference group.

Conditions

  • Weight Gain

Interventions

OTHER

EX_IMF

Infant formula with large amounts of beta-palmitate (about 60%).

OTHER

ST_IMF

Infant formula with low amounts beta-palmitate (about 10%).

Sponsors & Collaborators

  • Istituto di Ricerca Pediatrica Città della Speranza

    collaborator UNKNOWN

  • Bunge Loders Croklaan

    collaborator INDUSTRY

  • Ospedali Riuniti Ancona

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
24 Weeks
Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-16
Primary Completion
2025-12-31
Completion
2027-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04541095 on ClinicalTrials.gov